Moving the Needle in Undifferentiated Pleomorphic Sarcoma

In this series of OncChats: Moving the Needle in Undifferentiated Pleomorphic Sarcoma, experts discuss the multidisciplinary advances in treating undifferentiated pleomorphic sarcoma of the extremities, highlighting the benefits of combining pembrolizumab with radiation and surgery to improve disease-free survival.

EP. 1: Moving the Needle in Undifferentiated Pleomorphic Sarcoma: Overview of Paradigm

April 14th 2025

In this episode, experts discuss the latest advancements in the multimodal treatment of undifferentiated pleomorphic sarcoma of the extremities.

EP. 2: Moving the Needle in Undifferentiated Pleomorphic Sarcoma: Trial Design and Key Data

April 15th 2025

In this episode, experts discuss the rationale behind the combined treatment in the Stand Up to Cancer SARC 032 trial.

EP. 3: Moving the Needle in Undifferentiated Pleomorphic Sarcoma: Radiation Oncology and Immune Stimulation

April 16th 2025

In this episode, experts discuss the potential of radiation therapy to enhance immune response in soft tissue sarcomas.

EP. 4: Moving the Needle in Undifferentiated Pleomorphic Sarcoma: Surgical Oncology Goals

April 17th 2025

In this episode, experts shed light on the surgical approach to soft tissue sarcomas.

EP. 5: Moving the Needle in Undifferentiated Pleomorphic Sarcoma: Impact of Immunotherapy on Surgical Planning

April 18th 2025

In this episode, experts discuss the impact of neoadjuvant radiation and immunotherapy on surgical planning in patients with soft tissue sarcomas.

EP. 6: Moving the Needle in Undifferentiated Pleomorphic Sarcoma: Multidisciplinary Collaboration

April 19th 2025

In this episode, experts discuss the landmark SARC 032 study, highlighting the importance of multidisciplinary collaboration.

EP. 7: Moving the Needle in Undifferentiated Pleomorphic Sarcoma: Conclusions

April 20th 2025

In this episode, experts highlight the key takeaways from the Stand Up to Cancer SARC 032 study and its clinical implications.